Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2567648B2 - Cellulose acetate support for electrophoresis - Google Patents
[go: Go Back, main page]

JP2567648B2 - Cellulose acetate support for electrophoresis - Google Patents

Cellulose acetate support for electrophoresis

Info

Publication number
JP2567648B2
JP2567648B2 JP63051564A JP5156488A JP2567648B2 JP 2567648 B2 JP2567648 B2 JP 2567648B2 JP 63051564 A JP63051564 A JP 63051564A JP 5156488 A JP5156488 A JP 5156488A JP 2567648 B2 JP2567648 B2 JP 2567648B2
Authority
JP
Japan
Prior art keywords
cellulose acetate
support
electrophoresis
pore size
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63051564A
Other languages
Japanese (ja)
Other versions
JPH01227055A (en
Inventor
章 高橋
恵子 田家
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Roshi Kaisha Ltd
Original Assignee
Toyo Roshi Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Roshi Kaisha Ltd filed Critical Toyo Roshi Kaisha Ltd
Priority to JP63051564A priority Critical patent/JP2567648B2/en
Publication of JPH01227055A publication Critical patent/JPH01227055A/en
Application granted granted Critical
Publication of JP2567648B2 publication Critical patent/JP2567648B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明は電気泳動用支持体に関するものであり、特に
血清タンパクの分画電気泳動に使用されるセルロースア
セテートを主成分とした電気泳動用支持体に関するもの
である。
TECHNICAL FIELD The present invention relates to an electrophoretic support, and particularly to an electrophoretic support containing cellulose acetate as a main component used for fractional electrophoresis of serum proteins. It is about the body.

(従来の技術) セルロースアセテート膜電気泳動法による血清タンパ
ク分画は、現在、病院等におけ臨床検査の日常検査法と
して広く実施されている。この場合、通常、試料の血清
タンパクはアルブミン、α−グロブリン、α−グロ
ブリン、β−グロブリン、γ−グロブリンの5分画に分
離され、それぞれの分画百分率を測定して疾病の有無、
種類、程度等を診断する材料とされる。このため、5分
画の分画百分率を正確に測定することは極めて大切であ
る。しかしながら、従来のセルロースアセテート支持体
では試料塗布点(原点)がこの分画帯又は分画部に重な
り合ったり、又泳動後も試料残渣が塗布点に残るため、
しばしば測定時の誤差の原因となっていた。
(Prior Art) Serum protein fractionation by cellulose acetate membrane electrophoresis is now widely practiced as a routine test method for clinical tests in hospitals and the like. In this case, the serum protein of the sample is usually separated into five fractions of albumin, α 1 -globulin, α 2 -globulin, β-globulin, and γ-globulin, and the percentage fraction of each fraction is measured to determine the presence or absence of disease.
It is used as a material for diagnosing type, degree, etc. Therefore, it is extremely important to accurately measure the fractional percentage of the five fractions. However, in the case of the conventional cellulose acetate support, the sample application point (origin) overlaps with this fraction band or fraction part, and the sample residue remains at the application point even after migration,
It often caused an error in measurement.

このため、この様な欠点のない支持体の開発が強く望
まれていた。
For this reason, there has been a strong demand for the development of a support having no such disadvantages.

(発明が解決しようとする課題) 本発明はこれらの要望に応え、上記の諸欠点を除き、
血清タンパクの正確な分画百分率の測定が行える様に、
塗布点を分画帯より完全に分離し、且つ試料残渣の生じ
ないセルロースアセテートを主体とする新しい電気泳動
用支持体を提供しようとするものである。
(Problems to be Solved by the Invention) The present invention meets these needs and eliminates the above-mentioned drawbacks.
In order to be able to measure the accurate fractional fraction of serum proteins,
The present invention intends to provide a new electrophoretic support mainly composed of cellulose acetate, in which the application point is completely separated from the fractionated zone and a sample residue is not generated.

血清タンパクの電気泳動において分画部はなるべく支
持体の中央部に展開されることが必要である。しかしこ
のためには塗布点を決定するに際し、支持体の電気浸透
現象の影響を考慮しなければならない。
In electrophoresis of serum proteins, it is necessary that the fractionation part is developed in the central part of the support as much as possible. However, for this purpose, the influence of the electroosmotic phenomenon of the support must be taken into consideration when determining the coating point.

現在、市場にて販売されている一般の電気泳動用支持
体の電気浸透係数を特公昭55−31418号公報記載の方法
により測定したところ、マイナス20mm乃至マイナス4.5m
mの範囲にあった。例えばある種の市販品は電気浸透係
数が約マイナス20mmであり、最適塗布点は負極側より7:
3の位置である。しかしこの塗布点はα−グロブリン
分画部と重畳する。又他の市販品は電気浸透係数が約マ
イナス4.5mmで、最適塗布点は負極側より3:7の位置であ
り、この場合、塗布点はγ−グロブリンの末端に位置す
る。
The electro-osmotic coefficient of a general electrophoretic support currently sold in the market is measured by the method described in JP-B-55-31418, and it is found to be minus 20 mm to minus 4.5 m.
was in the m range. For example, some commercial products have an electro-osmotic coefficient of about -20 mm, and the optimum application point is 7:
Position 3 However, this application point overlaps with the α 1 -globulin fraction. In other commercially available products, the electroosmotic coefficient is about −4.5 mm, and the optimum application point is at the position of 3: 7 from the negative electrode side. In this case, the application point is located at the end of γ-globulin.

この様に従来の市販品は殆んど全て塗布点が分画帯内
に含まれ、更に泳動後でも塗布点に試料残渣の存在が明
らかに認められるので分画タンパクの百分率の正確な測
定は不可能である。
As described above, almost all the conventional commercial products have the application point in the fraction band, and the presence of the sample residue at the application point is clearly recognized even after the electrophoresis. Therefore, the percentage of the fractionated protein cannot be accurately measured. It is impossible.

また、最近「等電点分画用」として電気浸透係数0の
セルロースアセテート支持体が市販されているが、これ
を使って血清タンパクの電気泳動を行ったところ塗布点
とタンパク分画帯は分離するが塗布点における塗布残渣
量が大きく百分率が不正確になるばかりか、この残渣を
分画部と誤認しやすいため、血清分画用としての使用は
不可能であった。
Recently, a cellulose acetate support with an electroosmotic coefficient of 0 has been marketed as "for isoelectric point fractionation". When serum protein electrophoresis was performed using this, the application point and the protein fractionation zone were separated. However, not only the amount of coating residue at the coating point is large and the percentage becomes inaccurate, but also this residue is easily misidentified as a fractionation part, so that it cannot be used for serum fractionation.

(課題を解決するための手段) これらの点を改良するため、本発明者等は鋭意検討を
重ねた結果、セルロースアセテートを主成分とする微多
孔質膜において電気浸透係数が0未満乃至マイナス3mm
の範囲内にあり、且つその平均孔径を0.2〜5μm、試
料塗布面の表面孔径を10〜30μmの範囲内にすることに
より、原点をタンパク分画帯と完全に分離させ、泳動
後、塗布残渣が塗布点に残らず、しかも各々の分画が鮮
明な支持体が得られることを見出した。
(Means for Solving the Problems) In order to improve these points, the inventors of the present invention have conducted extensive studies, and as a result, have found that the microporous membrane containing cellulose acetate as a main component has an electroosmotic coefficient of less than 0 to minus 3 mm.
, The average pore diameter is 0.2 to 5 μm, and the surface pore diameter of the sample application surface is 10 to 30 μm, so that the origin is completely separated from the protein fraction band, and after application, the application residue It was found that a support in which each of the fractions was clear was obtained.

本発明において主材料のセルロースアセテートはジア
セテート及びトリアセテートの混合物が適し、特に両者
の等量混合物が好ましい。又これから多孔質膜を作るの
はセルロースアセテートをその親溶剤、貧溶剤、非溶剤
の場合溶媒に溶かして作ったドープを流延、乾燥させる
高分子多孔質膜の製造法の一種である相分離法によって
行われる。
In the present invention, the main material, cellulose acetate, is preferably a mixture of diacetate and triacetate, particularly preferably an equal mixture of both. A porous membrane is made from this by phase separation, which is one of the methods for producing a polymer porous membrane by casting and drying a dope made by dissolving cellulose acetate in its parent solvent, a poor solvent, or a non-solvent in the case of a non-solvent. Done by law.

親溶剤としては例えばアセトン、酢酸エチル、塩化メ
チレン等がある。貧溶剤の例としてはテトラヒドロフラ
ン、メタノール、エタノール等である。非溶剤としては
多くの場合水が用いられている。この混合溶媒に1〜20
%の濃度にセルロースアセテートが溶解される。
Examples of the hydrophilic solvent include acetone, ethyl acetate, methylene chloride and the like. Examples of poor solvents are tetrahydrofuran, methanol, ethanol and the like. Water is often used as the non-solvent. 1 to 20 in this mixed solvent
Cellulose acetate is dissolved to a concentration of%.

膜の電気浸透係数を0未満乃至マイナス3mmに調節す
るための方法として、ヒドロキシエチル、ヒドロキシプ
ロピル、ヒドロキシプロピルメチル等のセルロースエー
テル、或いはポリビニールアルコール等を添加剤として
加えることが効果的である。添加方法としてはドープ中
に加えるか、出来た膜への2次処理等がある。この場
合、セルロースアセテートに対する添加量を調節するこ
とによって電気浸透係数を所望の値にし、塗布点と分画
帯をある程度任意の距離に分離することが可能である。
したがってこの支持体の塗布点は負極側より3:7乃至0:1
0の広い範囲に設定することが可能である。しかし実際
には血清塗布などの操作上、負極側より3:7乃至1:9の範
囲が好ましく、特に負極側より2:8の位置が好適であ
る。又、塗布点と分画帯の分離距離は1mm未満の場合で
はデンシトメータ等の測定器の精度などにより隣接して
いるγ−グロブリン分画値に影響する場合があり、1mm
以上分離することが望ましい。又塗布点が負極側より2:
8の位置の場合タンパク分画帯を支持体中央部に展開す
るためには、膜の電気浸透係数がマイナス3.0mmより大
きく、好ましくはマイナス1mm乃至2mmが必要である。こ
の場合、塗布点と分画帯とは2mm乃至3mm程度分離する。
これらの目的を達するための好ましい添加剤の量は主成
分のセルロースアセテートに対し3〜5%である。
As a method for adjusting the electroosmotic coefficient of the membrane to less than 0 to minus 3 mm, it is effective to add cellulose ether such as hydroxyethyl, hydroxypropyl or hydroxypropylmethyl, or polyvinyl alcohol as an additive. As the addition method, there is a method such as addition to the dope or a secondary treatment to the formed film. In this case, it is possible to adjust the electroosmosis coefficient to a desired value by adjusting the amount added to the cellulose acetate, and to separate the application point and the fractional zone at an arbitrary distance to some extent.
Therefore, the coating point of this support is 3: 7 to 0: 1 from the negative electrode side.
It can be set in a wide range of 0. However, in practice, from the viewpoint of operation such as application of serum, the range of 3: 7 to 1: 9 is preferable from the negative electrode side, and the position of 2: 8 from the negative electrode side is particularly preferable. If the separation distance between the application point and the fraction zone is less than 1 mm, the accuracy of the measuring instrument such as a densitometer may affect the adjacent γ-globulin fractional value.
It is desirable to separate the above. Also, the coating point is from the negative electrode side 2:
In the case of position 8, in order to develop the protein fraction band in the central part of the support, the electroosmotic coefficient of the membrane must be larger than minus 3.0 mm, preferably minus 1 mm to 2 mm. In this case, the application point and the separation zone are separated by about 2 mm to 3 mm.
The preferable amount of the additive for achieving these purposes is 3 to 5% based on the cellulose acetate as the main component.

更に本発明者等の調査した結果、支持体の孔構造がそ
の泳動時間や電気抵抗と共に分画帯の鮮明度、試料残渣
の有無等に大きく影響を及ぼすことが判明した。そして
支持体の血清塗布面の表面孔径を10〜30μm、好ましく
は15〜20μmとすることにより、血清タンパクの付着防
止及び血清の内部浸透性の向上により塗布残渣のない支
持体が得られることを見い出した。
Further, as a result of the investigation by the present inventors, it was found that the pore structure of the support greatly affects the migration time, the electric resistance, the sharpness of the fraction band, the presence or absence of the sample residue, and the like. By setting the surface pore size of the support-coated surface of the serum to 10 to 30 μm, preferably 15 to 20 μm, it is possible to obtain a support having no coating residue by preventing adhesion of serum proteins and improving internal permeability of serum. I found it.

しかし表面孔径と平均孔径が同じ場合、特に10μm以
上の平均孔径を持つ支持体では泳動中に拡散現象が大き
く出てタンパク分画が不鮮明になりやすい。従って平均
孔径が0.2〜5μm、好ましくは0.4〜3μm、表面孔径
が10〜30μm、好ましくは15〜20μmとすることにより
鮮明なタンパク分画帯像を得、かつ塗布点に塗布残渣の
残らない支持体を得ることが可能である。
However, when the surface pore size and the average pore size are the same, particularly with a support having an average pore size of 10 μm or more, the diffusion phenomenon becomes large during migration and the protein fraction is liable to become unclear. Therefore, by setting the average pore size to 0.2 to 5 μm, preferably 0.4 to 3 μm, and the surface pore size to 10 to 30 μm, preferably 15 to 20 μm, a clear protein fraction band image can be obtained and no coating residue remains at the coating point. It is possible to get a body.

この支持体の表面及び平均孔径の調節は混合溶媒の組
合せを含めたドープ組成、及び製膜条件等で行える。更
に支持体の湿潤性を向上させるためにドープ中のセルロ
ースアセテートに対し1〜15%(重量)の非イオン性界
面活性剤が加えられる。特に3〜7%程度が好ましい。
尚、本発明の支持体の表面孔径は膜の試料塗布表面の孔
径を電子顕微鏡で計測して表示したものである。又、平
均孔径はポリシメータ法で計測した平均孔径をもって表
わしている。
The surface and average pore size of the support can be controlled by the dope composition including the combination of the mixed solvents, the film forming conditions, and the like. Further, in order to improve the wettability of the support, 1 to 15% (by weight) of a nonionic surfactant is added to the cellulose acetate in the dope. Particularly, about 3 to 7% is preferable.
The surface pore size of the support of the present invention is a value obtained by measuring the pore size of the sample-coated surface of the film with an electron microscope. Further, the average pore diameter is represented by the average pore diameter measured by the polysimeter method.

以下、実験例によって本発明を更に詳細に説明する。 Hereinafter, the present invention will be described in more detail with reference to experimental examples.

上記組成で均一なドープを作った。この溶液をガラス
板上に厚さ1mmに流延し、温度25℃、湿度65%の雰囲気
中で20分間放置した後ガラス板から生成した膜をはが
し、60℃のオーブン乾燥機中で更に1時間乾燥を行っ
た。得られた皮膜は上表の様な物性をもっていた。
A uniform dope was made with the above composition. This solution was cast on a glass plate to a thickness of 1 mm, allowed to stand for 20 minutes in an atmosphere of a temperature of 25 ° C. and a humidity of 65%, the film produced from the glass plate was peeled off, and further dried in an oven dryer at 60 ° C. It was dried for an hour. The obtained film had the physical properties shown in the above table.

この皮膜を22cm×6cmの大きさに切断し、ベロナー
ル、ベロナールナトリウム緩衝液(pH8.6、0.05mol/
)に湿した後、アドバンテック東洋社製電気泳動槽SE
−33に装填、ゲルマン社製コントロール血清をアプリケ
ータを使って0.5μづつ、長さ1cmに20ケ塗布した。
(塗布位置:比較例1、実施例1及び2は負極側から2:
8、比較例2は負極側から4:6の位置に塗布した)常法に
よって0.5mA/cmの電流で、30分間電気泳動を行った。次
いでその膜を6%のトリクロロ酢酸水溶液中に溶かした
0.6%ポンソー3R(和光純薬)溶液中に3分浸漬、染
色、更に2%酢酸水溶液で1〜2分づつ5回脱色処理し
た。その結果、実施例1,2及び比較例1ではその血清は
5分画に分離していたが、比較例2では6分画に分離し
ていた。
This film is cut into a size of 22 cm × 6 cm, and veronal and veronal sodium buffer (pH 8.6, 0.05 mol /
), And then ADVANTEC Toyosha electrophoresis tank SE
It was loaded in −33 and 0.5 μm each of the germane control serum was applied by an applicator at a length of 1 cm to 20 pieces.
(Coating position: Comparative Example 1, Examples 1 and 2 are from the negative electrode side 2:
8, Comparative Example 2 was applied at a position of 4: 6 from the negative electrode side) and electrophoresed at a current of 0.5 mA / cm for 30 minutes by a conventional method. The membrane was then dissolved in 6% aqueous trichloroacetic acid solution.
It was immersed in a 0.6% Ponceau 3R (Wako Pure Chemical Industries) solution for 3 minutes, dyed, and further decolorized 5 times with a 2% acetic acid aqueous solution for 1 to 2 minutes. As a result, the serum was separated into 5 fractions in Examples 1 and 2 and Comparative Example 1, but was separated into 6 fractions in Comparative Example 2.

結果を次に示す。 The results are shown below.

市販品の1種を上と同じ条件で電気泳動した。結果は次
の如くである。
One of the commercially available products was electrophoresed under the same conditions as above. The results are as follows.

【図面の簡単な説明】[Brief description of drawings]

第1図〜第4図は染色、脱色、乾燥後の電気泳動像図を
デンシトメータ(濃度計:萓垣製作所製ADC−25EX)で
走査し、各分画部の吸光度を連続測定したもので、第1
図は実施例1,第2図は比較例1,第3図は比較例2,第4図
は市販品の各分画部の吸光度を示す。
Figures 1 to 4 are electrophoretic image diagrams after staining, decolorization and drying, which were scanned with a densitometer (densitometer: ADC-25EX manufactured by Kagaki Seisakusho), and the absorbance of each fractionation part was continuously measured. First
The figure shows Example 1, FIG. 2 shows Comparative Example 1, FIG. 3 shows Comparative Example 2, and FIG. 4 shows the absorbance of each fractionation part of a commercial product.

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】セルロースアセテートを主成分とする微多
孔質膜であり、電気浸透係数が0未満乃至マイナス3mm
の範囲にあり、且つ、その平均孔径が0.2〜5μm、表
面孔径が10〜30μmの範囲内にあることを特徴とする電
気泳動用セルロースアセテート支持体。
1. A microporous membrane containing cellulose acetate as a main component and having an electroosmotic coefficient of less than 0 to minus 3 mm.
And an average pore size of 0.2 to 5 μm and a surface pore size of 10 to 30 μm.
JP63051564A 1988-03-07 1988-03-07 Cellulose acetate support for electrophoresis Expired - Lifetime JP2567648B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63051564A JP2567648B2 (en) 1988-03-07 1988-03-07 Cellulose acetate support for electrophoresis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63051564A JP2567648B2 (en) 1988-03-07 1988-03-07 Cellulose acetate support for electrophoresis

Publications (2)

Publication Number Publication Date
JPH01227055A JPH01227055A (en) 1989-09-11
JP2567648B2 true JP2567648B2 (en) 1996-12-25

Family

ID=12890464

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63051564A Expired - Lifetime JP2567648B2 (en) 1988-03-07 1988-03-07 Cellulose acetate support for electrophoresis

Country Status (1)

Country Link
JP (1) JP2567648B2 (en)

Also Published As

Publication number Publication date
JPH01227055A (en) 1989-09-11

Similar Documents

Publication Publication Date Title
Radola Thin-layer gel filtration of proteins I. Method
Gordon Electrophoresis of Proteins in Polyacrylamide and Starch Gels: Laboratory Techniques in Biochemistry and Molecular Biology
CA2394948C (en) Screen-printable paste for producing a porous polymer membrane for a biosensor
USRE24752E (en) Method of electrophoresis of serum proteins
CA2117692C (en) Heparin-selective polymeric membrane electrode
JPWO2008047703A1 (en) Method for measuring hemoglobins
JPH022913A (en) Modified electrode
US4668359A (en) Diagnostic strip
US4199412A (en) Halide ion-selective devices and method
Tang et al. A method for routine analysis of recombinant immunoglobulins (rIgGs) by capillary isoelectric focusing (cIEF)
JP2567648B2 (en) Cellulose acetate support for electrophoresis
US5068019A (en) Electrophoresis film support
EP0401486A1 (en) Selectively permeable membrane
US4128470A (en) Supports for electrophoresis and process for the production of the same
EP0255328A2 (en) Improved sodium ion selective electrode and method of use
McDonald Ionography: A new frontier in electrophoresis
Tulchin et al. A microgel system for disc electrophoresis
Van Oss et al. Characteristics of a protein concentrating anisotropic cellulose acetate membrane
JPS6330571B2 (en)
EP0288724B1 (en) Ion-selective electrode for measuring carbonate concentration
Davisson et al. Rat Liver Lactic Dehydrogenase. II. Physico-chemical Studies on the Crystalline Enzyme
Kinzkofer‐Peresch et al. Native protein blotting after isoelectric focusing in fabric reinforced polyacrylamide gels in carrier ampholyte generated or immobilized pH gradients
JP3196123B2 (en) Cellulose acetate support for electrophoresis
Vergani Crossover electrophoresis for the rapid detection of serum hepatitis (Australia) antigen and antibody
JP2009109231A (en) Method for measuring stable hemoglobin A1c value

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20081003

Year of fee payment: 12